Jump to content

Could this common painkiller become a future cancer-killer?

Paul Edwards

Recommended Posts

What if we could treat cancer with cheap generic drugs that have been used for a long time and whose side effects are well-known?


This is what the Repurposing Drugs in Oncology (ReDO) project is looking at.  It is an international collaboration initiated by a diverse group of researchers, clinicians and patient advocates all working in the not-for-profit sector.  Their goal is to seek new and effective cancer treatments with low toxicity that meet the needs of existing patients in as short a time-frame as possible and at a cost that is affordable both in developed and developing countries.


Click on this link to read about the ReDO Project's investigation of Diclofenac.

Link to comment
Share on other sites


This topic is now archived and is closed to further replies.

  • Create New...